Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?

por Adashek, Jacob J., Subbiah, Ishwaria M., Matos, Ignacio, Garralda, Elena, Menta, Arjun K., Ganeshan, Dhakshina Moorthy, Subbiah, Vivek
Publicado 2020

Current update on combined hepatocellular-cholangiocarcinoma

por Maximin, Suresh, Ganeshan, Dhakshina Moorthy, Shanbhogue, Alampady K., Dighe, Manjiri K., Yeh, Matthew M., Kolokythas, Orpheus, Bhargava, Puneet, Lalwani, Neeraj
Publicado 2014

STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harbo...

por Subbiah, Vivek, McMahon, Caitlin, Patel, Shreyaskumar, Zinner, Ralph, Silva, Elvio G, Elvin, Julia A., Subbiah, Ishwaria M., Ohaji, Chimela, Ganeshan, Dhakshina Moorthy, Anand, Deepa, Levenback, Charles F., Berry, Jenny, Brennan, Tim, Chmielecki, Juliann, Chalmers, Zachary R., Mayfield, John, Miller, Vincent A., Stephens, Philip J., Ross, Jeffrey S., Ali, Siraj M.
Publicado 2015